Santoni-Rugiu Group

Our main research area concerns thoracic malignancies such as non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM), which are among the most lethal human cancer types, as they spread rapidly, are diagnosed late, and respond poorly to standard treatment. Thus, we aim at identifying new biomarkers for earlier diagnosis and more effective targeted treatments of these extremely aggressive cancers.